This grant is for advancing the detection of new and evolving drug threats within the illicit supply. As substances like xylazine and nitazenes emerge, there’s a critical need for analytical methods beyond traditional testing strips, which may not exist for novel compounds. The grant seeks proposals focusing on instrumentation for sensitive and sample-agnostic analytical techniques capable of identifying these unknown or emerging substances in real-world samples. This initiative aims to equip researchers and public health officials with advanced tools to understand and respond to the continuously changing landscape of illicit drugs, ensuring effective monitoring and intervention strategies for public safety and health.
Opportunity ID: 356956
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-26-018 |
| Funding Opportunity Title: | Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 – Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Use and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 04, 2024 |
| Last Updated Date: | Nov 04, 2024 |
| Original Closing Date for Applications: | Feb 19, 2025 |
| Current Closing Date for Applications: | Feb 19, 2025 |
| Archive Date: | Mar 27, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: See NOFO for further eligibility details. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Emerging threats continuously evolve. Xylazine, nitazenes, and other future threats are making their way or are already in the drug supply. Understanding them requires analyzing real world samples. Typically, testing strips are used to detect drug for which such strip exists, as the strips are fast, sensitive, low cost and reasonably accurate. However, as there might not be testing strips for the new threats, the analysis must be performed via sensitive and sample agnostic methods. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-26-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356956 Full Announcement-RFA-DA-26-018 -> RFA-DA-26-018-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288455 | Jan 19, 2025 | Feb 19, 2025 | View |
Package 1
Mandatory forms
356956 RR_SF424_5_0-5.0.pdf
356956 PHS398_CoverPageSupplement_5_0-5.0.pdf
356956 RR_OtherProjectInfo_1_4-1.4.pdf
356956 PerformanceSite_4_0-4.0.pdf
356956 RR_KeyPersonExpanded_4_0-4.0.pdf
356956 RR_Budget_3_0-3.0.pdf
356956 PHS398_ResearchPlan_5_0-5.0.pdf
356956 SBIR_STTR_Information_3_0-3.0.pdf
356956 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356956 RR_SubawardBudget30_3_0-3.0.pdf
356956 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
